Structural Heart Disease

Showing 1022 articles
Business

LendingClub's Hybrid Model: A Bullish Bet on Fintech's Evolution

LendingClub Corporation (NYSE: LC), having transformed into a hybrid digital bank and marketplace, is drawing investor attention for its dual revenue streams and strategic pivot post-Radius Bank acquisition. With shares trading around $16.44 and a forward P/E of 9.64, bulls argue its unique structure positions it for steadier growth in a volatile market.

Business

Bridgestone's Stock: A Year of Strong Gains Raises Valuation Questions

Bridgestone Corporation's shares have delivered a robust 33% total return to shareholders over the past year, outpacing its recent short-term volatility. This performance prompts a closer look at whether the tire giant's current valuation still offers room for growth or if the market has already priced in its future prospects.

Business

C4 Therapeutics: Can Its Protein-Degrading Tech Ignite a Biotech Rally?

Amid a challenging market for biotech, C4 Therapeutics (NASDAQ: CCCC) is drawing investor attention with its targeted protein degradation platform. Backed by industry giants and focused on niche cancers, the clinical-stage company presents a high-risk, high-reward proposition. We examine the bull case and the road ahead.

Business

From Bitcoin Miner to AI Powerhouse: How Cipher Mining Is Fueling the Data Center Boom

Cipher Mining Inc. (CIFR), once a traditional cryptocurrency miner, has rapidly transformed into a key developer of industrial-scale data centers, capitalizing on the insatiable power demands of artificial intelligence. With a portfolio exceeding 3 gigawatts, primarily in power-rich West Texas, the company is now building the physical backbone for tech giants. This strategic pivot, however, raises critical questions about capital allocation and the sustainability of the AI infrastructure rush.